ERBB2 and neoplasm: A retrospective analysis of large sample data from GSE96058 and METABRIC cohorts showed that PKMYT1 expression was higher in high tumor grade, advanced tumor size stage, advanced lymph node metastasis stage, HER2 positive status, and ER negative status (Figures 2A–J).